BioSpace News Archive

Astria Therapeutics today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a corporate update.

DermBiont today announced that its Phase 2 adaptive design trial with of investigational drug SM-020 gel 1.0% met its primary endpoint of a one point improvement in Physician’s lesion assessment (PLA) score at last visit and safety via local tolerability, as well as key multiple secondary endpoints including complete clearance of treated lesions.

Axena Health, Inc. announced that Cigna Healthcare, one of the largest healthcare insurance providers in the United States with approximately 15 million members, has added the Leva Pelvic Health System as a covered treatment for stress, urgency and mixed urinary incontinence in women.

Visus Therapeutics Completes Enrollment in BRIO-I, a Phase 3 Clinical Trial of BRIMOCHOL ™ PF for the Treatment of Presbyopia.

Ancora Heart, Inc today announced that patients treated with the investigational AccuCinch ® Ventricular Restoration System demonstrated improvement in HF patient outcomes and beneficial changes in the structure of the heart.

Spectrum Pharmaceuticals, Inc. announced today financial results for the three-month period and full year ended December 31, 2022.

Standard BioTools Inc. (Nasdaq:LAB) today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, granted an equity award effective as of March 20, 2023, under the Standard BioTools Inc.

Acer Therapeutics Inc. (Nasdaq: ACER) today announced data was presented from a survey designed to quantify preferences of healthcare providers for Urea Cycle Disorders (UCDs) at the 44th Annual Meeting of the Society for Inherited Metabolic Disorders (SIMD), March 18th-21st in Salt Lake City, Utah.

Aziyo Biologics, Inc. and Sientra, Inc. today announced they have entered into an agreement to expand the distribution of Aziyo’s SimpliDerm product line.

Gain Therapeutics, Inc. today announced that it will participate in a virtual panel discussion on recent advances in AI-enabled computational biology and the future of drug discovery.